Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 218, Issue 12, Pages -Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20210639
Keywords
-
Categories
Funding
- Ministry of Education, Culture, Sports, Science and Technology (MEXT Japan) [18H04665, 20H03455, 26221305, JP19H05650, 20K21618]
- Japan Agency for Medical Research and Development (AMED) [JP21ek0410060]
- AMED-CREST [JP21gm1210003]
- Nakajima Foundation
- Terumo Foundation for Life Sciences and Arts
- Tokyo Biochemical Research Foundation
- Kato Memorial Bioscience Foundation
- Hamaguchi Foundation for the Advancement of Biochemistry, Suzuken Memorial Foundation
- Kanae Foundation for the Promotion of Medical Science
- Takeda Science Foundation
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- SENSHIN Medical Research Foundation
- Sumitomo Foundation, Koyanagi Foundation
- Uehara Memorial Foundation
- Nakatomi Foundation
- Cell Science Research Foundation
- Astellas Foundation for Research on Metabolic Disorders
- MSD Life Science Foundation
- Public Interest Incorporated Foundation
- Nagase Science Technology Foundation
Ask authors/readers for more resources
The study reveals that pathogenic CD4(+) T cells in the lungs and skin exhibit high levels of ACC1. ACC1 regulates the inflammatory function of pathogenic CD4(+) T cell population to promote type 2 inflammation in the lungs and skin.
T cells possess distinguishing effector functions and drive inflammatory disorders. We have previously identified IL-5-producing Th2 cells as the pathogenic population predominantly involved in the pathology of allergic inflammation. However, the cell-intrinsic signaling pathways that control the pathogenic Th2 cell function are still unclear. We herein report the high expression of acetyl-CoA carboxylase 1 (ACC1) in the pathogenic CD4(+) T cell population in the lung and skin. The genetic deletion of CD4(+) T cell-intrinsic ACC1 dampened eosinophilic and basophilic inflammation in the lung and skin by constraining IL-5 or IL-3 production. Mechanistically, ACC1-dependent fatty acid biosynthesis induces the pathogenic cytokine production of CD4(+) T cells via metabolic reprogramming and the availability of acetyl-CoA for epigenetic regulation. We thus identified a distinct phenotype of the pathogenic T cell population in the lung and skin, and ACC1 was shown to be an essential regulator controlling the pathogenic function of these populations to promote type 2 inflammation. The authors find that lung and skin pathogenic CD4(+) T cells express high levels of ACC1. ACC1 controls the inflammatory function of the pathogenic CD4(+) T cell population to promote type 2 inflammation in the lung and skin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available